The role of hepatitis E virus infection in adult Americans with acute liver failure

Hepatology

Volumn 64, Issue 6, 2016, Pages 1870-1880

  Fontana, Robert John ^a   Engle, Ronald E ^b   Scaglione, Steven ^c   Araya, Victor ^d   Shaikh, Obaid ^e   Tillman, Holly ^f   Attar, Nahid ^g   Purcell, Robert H ^b   Lee, William M ^g  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d EINSTEIN MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; AMLODIPINE; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; BILIRUBIN; COLESTYRAMINE; CREATININE; DIAZEPAM; ESOMEPRAZOLE; FAMOTIDINE; HEMOGLOBIN; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS E ANTIBODY; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; IMMUNOGLOBULIN M; METOPROLOL; MULTIVITAMIN; MYCOPHENOLIC ACID; OXYCODONE; PARACETAMOL; VIRUS RNA; HEPATITIS ANTIBODY; IMMUNOGLOBULIN G;

ABDOMINAL PAIN; ACUTE LIVER FAILURE; ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROSCLEROSIS; BILIRUBIN BLOOD LEVEL; BRAIN DISEASE; CAROTID ARTERY DISEASE; CHOLESTASIS; CREATININE BLOOD LEVEL; DEPRESSION; DISEASE DURATION; DRUG INTOXICATION; EMERGENCY SURGERY; FEMALE; FEVER; HEPATITIS E; HUMAN; HYPERLIPIDEMIA; JAUNDICE; LEG EDEMA; LEUKOCYTE COUNT; LIVER BIOPSY; LIVER CELL; LIVER TOXICITY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALAISE; MALE; MENTAL HEALTH; MIGRAINE; NAUSEA; NORTH AMERICAN; OVERALL SURVIVAL; PH; PLASMA CELL; PRIORITY JOURNAL; SEROPREVALENCE; SERUM; SPINE FUSION; TOXIC HEPATITIS; UNITED STATES; VOMITING; WEAKNESS; AGED; BLOOD; CASE REPORT; COMPLICATION; HEPATITIS E VIRUS; IMMUNOLOGY; PROSPECTIVE STUDY; SEROEPIDEMIOLOGY;

ADULT; AGED; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIVER FAILURE, ACUTE; MALE; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES;

EID: 84977090741     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28649     Document Type: Article

References (36)

1. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008;48:494-503.
2. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. New Engl J Med 2012;367:1237-1244.
3. Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007;147:28-33.
4. Kar P, Jilani N, Husain SA, Pasha ST, Anand R, Rai A, Das BC. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy. Am J Gastroenterol 2008;103:2495-2501.
5. Acharya SK, Sharma PK, Singh R, Mohanty SK, Madan K, Jha JK, Panda SK. Hepatitis E virus infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol 2007;46:387-394.
6. Hamid SS, Atiq M, Shehzad F, Yasmeen A, Nissa T, Salam A, et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology 2002;36:474-478.
7. Peron E. Fulminant liver failure from acute authochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hep 2007;15;298-303.
8. Manka P, Bechmann LP, Coombes JD, Thodou V, Schlattjan M, Kahraman A, et al. Hepatitis E virus infection as a possible cause of acute liver failure in Europe. Clin Gastroenterol Hepatol 2015;13:1836-1842.e2
9. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the third NHANES, survey, 1988-1994. J Infect Dis 2009;200:48-56.
10. Wichmann O, Schimanski S, Koch J, Kohler M, Rothe C, Pletnz A, et al. Phylogenetic and case control study on hepatitis E virus infection in Germany. J Infect Dis 2008;198:1732-1741.
11. Dalton HR, Fellows HJ, Stableforth W, Joseph M, Thurairajah PH, Warshow U, et al. The role of hepatitis E virus testing in drug-induced liver Injury. Aliment Pharmacol Ther 2007;26:1429-1435.
12. Dalton HR, Fellows HJ, Gane E, Wong P, Gerred S, Schroeder B, et al. Hepatitis E in New Zealand. J Gastroenterol Hepatol 2007;22:1236-1240.
13. Davern TJ, Chalasani N, Fontana RJ, Hayashi PH, Protiva P, Kleiner DE, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011;141:1665-1672.
14. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-954.
15. Levitsky J, Duddempudi AT, Lakeman FD, Whitley RJ, Luby JP, Lee WM, et al. Detection and diagnosis of herpes simplex virus infection in adults with acute liver failure. Liver Transpl 2008;14:1498-1504.
16. Umemura T, Tanaka E, Ostapowicz G, Brown KE, Heringlake S, Tassopoulos NC, et al. Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis. J Infect Dis 2003;188:1545-1552.
17. Lee WM, Brown KE, Young NS, Dawson GJ, Schlauder GG, Gutierrez RA, et al. Brief report: no evidence for parvovirus B19 or hepatitis E virus as a cause of acute liver failure. Digest Dis Sci 2006;51:1712-1715.
18. Rangnekar AS, Ellerbe C, Durkalski V, McGuire B, Lee WM, Fontana RJ. Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen overdose patients. Liver Transpl 2013;19:991-1000.
19. Engle RE, Yu, C, Emerson SU, Meng XJ, Purcell RH. Hepatitis E virus capsid antigens derived from viruses of human and swine origine are equally efficient for detecting anti-HEV by enzyme immunoassay. J Clin Microbiol 2002;40:4576-4580.
20. Yu C, Engle RE, Bryan JP, Emerson SU, Purcell RH. Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay. Clin Diagn Lab Immunol 2003;10:579-586.
21. Bendall R Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a reevaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010;82:799-805.
22. Pas SD, Streefkerk RH, Pronk M, de Man RA, Beersma MF, Osterhaus AD, et al. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J Clin Virol 2013;58:629-634.
23. Holm DK, Moessner BK, Engle RE, Zaaijer HL, Georgsen J, Purcell RH, et al. Declining prevalence of hepatitis E antibodies among Danish blood donors. Transfusion 2015;55:1662-1667.
24. Shukla P, Nguyen HT, Torian U, Engle RE, Faulk K, Dalton HR, et al. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc Natl Acad Sci U S A 2011;108:2438-2443.
25. Khandelwal N, James LP, Sanders C, Larson AM, Lee WM. Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology 2011;53:567-576.
26. Stravitz TR, Lefkowitch JH, Fontana RJ, Gershwin ME, Leung PSC, Sterling RK, et al. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology 2011;53:517-526.
27. Drobeniuc J, Greene-Montfort T, Le NT, Mixson-Hayden TR, Ganova-Raeva L, Dong, C, et al. Laboratory based surveillance for hepatitis E virus infection, United States, 2005-2012. Emerg Infect Dis 2013;19:218-222.
28. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. New Engl J Med 2008;358:811-817.
29. Haagsma EB, Niesters HG, Van den berg AP, Riezebos-Brilman A, Porte RJ, Vennema H, et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 2009;15:149-150.
30. Kamar N, Abravanel F, Selves J, et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis E virus infection after organ transplantation. Transplantation 2010;89;353-359.
31. Kamar N, Legrand-Abravanel F, Izopet J, Rostaing L. Hepatitis E virus: what transplant physicians should know. Am J Transplant 2012;12:2281-2287.
32. Meng XJ, Purcell RH, Halbur PE, et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A 1997;94:9860-9865.
33. Nelson KE, Kmush B, Labrique AB. The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients. Expert Rev 2011;9:133-1148.
34. Meng XJ, Wiseman B, Elvinger F, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 2002;40:117-122.
35. Mast EE, Alter MJ, Holland PV, Purcell RH. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 1998;27:857-861.
36. Ditah I, Ditah F, Devaki P, Ditah C, Kamath PS, Charlton M. Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey. Hepatology 2014;64:815-822.